🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Intrahepatic cholangiocarcinoma (ICC) is associated with poor prognosis. Th...
Status
Completed
Location
Sun Yat-sen University Cancer Center
Start Date
2017-09-01
Trial ID
NCT05489692
The goal of this clinical trial is to explore the efficacy and safety of co...
Status
Recruiting
Location
Shandong Cancer Hospital and Institute
Start Date
2024-03-01
Trial ID
NCT06296563
Treatments Being Tested
Apatinib has been proved to be effective and safe among patients in advance...
Status
Unknown
Location
Multiple Locations
Start Date
2018-01-31
Trial ID
NCT03377842
Treatments Being Tested
Primary liver cancer is a malignant tumor with a very poor prognosis. Hepat...
Status
Not Yet Recruiting
Location
Zhejiang Cancer Hospital
Start Date
2027-09-01
Trial ID
NCT07691645
Treatments Being Tested
This study was designed to evaluate the effectiveness and safety of hepatic...
Status
Unknown
Location
Sun Yat-sen University Cancer Center
Start Date
2022-06-15
Trial ID
NCT05313282
The purpose of this study is to evaluate the safety and efficacy of hepatic...
Status
Active Not Recruiting
Location
The first hospital of China medical university
Start Date
2024-08-16
Trial ID
NCT06632106
This study used (cTACE or DEB-TACE + FOLFOX scheme HAIC) combined with PD-1...
Status
Unknown
Location
Multiple Locations
Start Date
2021-04
Trial ID
NCT04479527
Treatments Being Tested
This project is a prospective, multi-center, multi-cohort exploratory clini...
Status
Recruiting
Location
China Pharmaceutical University Affiliated Nanjing Tianyinshan Hospital
Start Date
2025-05-22
Trial ID
NCT06893887
This study aims to explore the value of the 'HAIC Apatinib Camrelizumab' tr...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-05-25
Trial ID
NCT07618546
Treatments Being Tested
Compare the efficacy and safety of camrelizumab, apatinib plus FOLFOX-HAIC ...
Status
Active Not Recruiting
Location
Cancer Center Sun Yat-sen University
Start Date
2022-01-17
Trial ID
NCT05198609
Treatments Being Tested